In Detail
Anxiety that appears or worsens during perimenopause and menopause is biologically driven, not a character flaw. Estrogen modulates serotonin, dopamine, and GABA — the same neurotransmitter systems targeted by most psychiatric medications. As estrogen levels swing or decline, mood regulation becomes more difficult.
Progesterone has a calming effect through its metabolite allopregnanolone, which acts on GABA receptors. The loss of progesterone in the second half of perimenopause often coincides with new sleep-onset anxiety, racing thoughts at night, and a sense of being 'wired but tired.'
Treatment is individualized. For some women, restoring progesterone alone is transformative. Others benefit from combined estrogen-progesterone therapy. A subset need or prefer non-hormonal mental health care, and these approaches are not mutually exclusive.